The TRICURE EU Pivotal Study
Not Applicable
Recruiting
- Conditions
- Tricuspid Valve RegurgitationHeart Valve DiseaseCardiovascular Diseases
- Interventions
- Device: Transcatheter Tricuspid Valve Replacement
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- TRiCares
- Target Recruit Count
- 80
- Registration Number
- NCT06581471
- Locations
- 🇧🇪
Algemeen Stedelijk Ziekenhuis, Aalst, Belgium
🇧🇪ZNA Middelheim, Antwerpen, Belgium
🇧🇪UZ Brussel, Bruxelles, Belgium
The TRICURE EFS Study
Not Applicable
Recruiting
- Conditions
- Tricuspid Valve RegurgitationHeart Valve DiseasesCardiovascular DiseasesTricuspid Valve RegurgitationHeart Valve DiseasesCardiovascular Diseases
- Interventions
- Device: Transcatheter Tricuspid Valve Replacement
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- TRiCares
- Target Recruit Count
- 10
- Registration Number
- NCT06506942
- Locations
- 🇺🇸
Piedmont Healthcare Inc., Atlanta, Georgia, United States
🇺🇸University of Michigan Hospital and Health Systems, Ann Arbor, Michigan, United States
🇺🇸Columbia University Medical Center/ NewYork Presbyterian Hospital, New York, New York, United States
The TRICURE First in Human Trial
Not Applicable
Active, not recruiting
- Conditions
- Tricuspid Regurgitation
- Interventions
- Device: Topaz TTVR System
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- TRiCares
- Target Recruit Count
- 20
- Registration Number
- NCT05126030
- Locations
- 🇧🇪
Algemeen Stedelijk Ziekenhuis,, Aalst, Belgium
🇧🇪ZNA Middelheim, Antwerpen, Belgium
🇫🇷University Hospital Lille, Institut Cœur Poumon, Lille, France
© Copyright 2025. All Rights Reserved by MedPath